H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.9% of adults in Los Angeles have diagnosed diabetes — about even with the U.S. 12% figure. Census population 3,979,576. California Medicare wound biologics: Noridian Healthcare Solutions (JE). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Los Angeles clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Los Angeles storefront.
Non-Opioid Pain Management Solutions in Los Angeles, CA for clinics & physicians. Non-opioid pain manageme… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 11.9% of adults in Los Angeles have diagnosed diabetes — about even with the U.S. 12% figure. Census city-proper population is 3,979,576. If you are adding non opioid pain management, start with that epidemiology and with Noridian Healthcare Solutions (JE) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Non-Opioid Pain Management Solutions notes (how the product actually works)JE reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Los Angeles is 11.9% or not. PLACES is planning data. The LCD is the claim.
We are not going to invent a Los Angeles warehouse or a five-star local review. What you get is non opioid pain management from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JE, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 11.9% of adults — about even with the U.S. 12% figure. Obesity is 27.3%; arthritis is 18.8%. That is place-level BRFSS modeling, not a clinic census and not a Los Angeles trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including California.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a California compliance risk.
California is JE. A sister clinic in another state may be a different contractor with different CTP articles. Do not assume one utilization policy ports. We map both if you operate across MACs.
If you operate in California and another MAC state, say it on the first call. JE will not port 1:1. We would rather split utilization than watch a sister clinic copy Los Angeles tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Los Angeles, CA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Los Angeles is JE geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Los Angeles — about even with the U.S. 12% figure. Planning input, not an outcomes claim.
California Part B wound biologics follow this contractor (siblings: HI, NV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Los Angeles. Useful for joint-program math; still needs a diagnosis and privileging.
No Los Angeles storefront. Joe Bradley is an active practice owner. non opioid pain management stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.